About Overture Life
Overture Life is a company based in Palo Alto (United States) founded in 2017 by Jose Horcajadas, Santiago Munne, and Martin Varsavsky. Overture Life has raised $49.2 million across 4 funding rounds from investors including Khosla Ventures, Overwater Ventures and Google Ventures. Overture Life operates in a competitive market with competitors including NuProbe, Good Start Genetics, Ascelia, Auxogyn and FDNA, among others.
- Headquarter Palo Alto, United States
- Founders Jose Horcajadas, Santiago Munne, Martin Varsavsky
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$49.2 M (USD)
in 4 rounds
-
Latest Funding Round
$23.05 M (USD), Debt – Conventional
Nov 04, 2025
-
Investors
Khosla Ventures
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Overture Life
Unlock access to complete
Unlock access to complete
Funding Insights of Overture Life
Overture Life has successfully raised a total of $49.2M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $23.05 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Overture Life
Overture Life has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include Khosla Ventures, Overwater Ventures and Google Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided to innovative founders.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked |
Investor details for Overture Life
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Overture Life
Investment portfolio details for Overture Life
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Overture Life
Detailed financials for Overture Life
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Overture Life Comparisons
Peer comparison for Overture Life
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Overture Life
Overture Life operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuProbe, Good Start Genetics, Ascelia, Auxogyn and FDNA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sensitive multiplex platforms for QPCR are developed using toehold probes.
|
|
| Locked | Locked | Locked |
Molecular diagnostics for inherited genetic disease screening are provided.
|
|
| Locked | Locked | Locked |
Developer of orphan drugs for treatment and diagnostics solutions
|
|
| Locked | Locked | Locked |
Diagnostic technologies for IVF embryo viability assessment are developed.
|
|
| Locked | Locked | Locked |
Neurogenetic solutions for facial dysmorphic feature detection are developed.
|
Detailed competitors of Overture Life
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Overture Life
Complete news archive for Overture Life
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Overture Life
Overture Life was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Overture Life is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Hans Gangeskar is the current CEO of Overture Life.
Overture Life is a funded company, having raised a total of $49.2M across 4 funding rounds to date.
Founded in 2017 and based in Palo Alto, United States, Overture Life operates in the biotechnology sector focused on reproductive medicine. Automated platforms like DaVitri are provided to streamline egg freezing and embryo warming processes, ensuring consistent timing and improved oocyte survival. Additionally, AI-powered metabolomic tests such as mz are offered for non-invasive embryo selection in clinical settings.
Overture Life has 7 investors. Key investors include Khosla Ventures, Overwater Ventures, Google Ventures, Octopus Ventures, and Felicis Ventures.